ArticleBlood advances2023

Characteristics and outcomes of patients with CLL and CDKN2A/B deletion by fluorescence in situ hybridization.

Samantha M Teierle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.